PPARGC1A and Cholestatic liver disease: To investigate the role of mitochondrial biogenesis in SIRT6's resistance to cholestatic liver disease, we administered the AMPK agonist AICAR to Sirt6Δhep mice, and observed a significant restoration of the AMPK phosphorylation and PGC-1α protein levels that were impaired by Sirt6 deletion.